LSTA FY 2024 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M100.0% margin

Operating Income

-$22M-2240.9% margin

Net Income

-$20M-1998.5% margin

EPS (Diluted)

$-2.40

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$35M

Total Liabilities

$6M

Stockholders' Equity

$30M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$22M	-$26M	+12.8%
Net Income	-$20M	-$21M	+4.1%